Enspryng 120 mg/mL prefilled syringe Images
Generic Name: satralizumab
This medication has been identified as Enspryng 120 mg/mL prefilled syringe. It is supplied by Genentech, Inc.
Enspryng is used in the treatment of Neuromyelitis Optica Spectrum Disorder and belongs to the drug class interleukin inhibitors. Enspryng 120 mg/mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Enspryng
- Generic Name
- satralizumab
- Strength
- 120 mg/mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0007
See also:
Uplizna
Uplizna is used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) or ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
More about Enspryng (satralizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.